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ABSTRACT: At the present time, there is still controversy concerning the presence
of a late asthmatic response (LAR) to exercise challenge in asthma.  We have, there-
fore, investigated the occurrence of a LAR after exercise in asthmatic children visi-
ting an out-patient clinic, using time-matched baseline and histamine control days,
and a statistical analysis according to recently published recommendations.
After a screening exercise day, 17 children (aged 7–14 yrs) randomly performed,
on three subsequent study days, either: a second standardized exercise challenge;
or a histamine challenge whilst matching the bronchoconstriction after exercise; or
measurement of baseline lung function without any challenge.  Measurements of
forced expiratory volume in one second (FEV1) were made repeatedly during 8 h.
Analysis was performed using multiple regression analysis for each patient, with
FEV1 as the dependent, and test day (exercise or control) and clock time as inde-
pendent variables during the period 2–8 h after exercise.  A significant interaction
(p<0.05) between test day and clock time was considered to be indicative of a LAR.
Fifteen children completed the study.  All children showed an early asthmatic
reaction to exercise (range 14–62% fall in FEV1).  In two children, a significant
interaction (p<0.05) was found between test day and clock time.  However, the dif-
ference in FEV1 between exercise and control days for each clock time did not
exceed the 99.6% confidence limits of normal diurnal variation in any of the chil-
dren.
We conclude that, in children with mild-to-moderate asthma, a LAR to exercise
does not occur.  This suggests that exercise is only a symptomatic trigger of asth-
ma.  Whether exercise is capable of inducing inflammation needs to be further inves-
tigated.
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It has long been recognized that exercise can induce
acute bronchoconstriction in patients with asthma [1], the
so-called exercise-induced bronchoconstriction (EIB).  In
childhood asthma, the prevalence of EIB ranges 70–90%
[2, 3].  Children suffering from EIB may complain about
any of the following symptoms during or after strenu-
ous exercise: wheezing, shortness of breath, cough or
chest pain [4, 5]. The bronchoconstrictor response to
exercise is determined by the level of ventilation reach-
ed during exercise, as well as the temperature and water
content of the inspired air [6]. The precise mechanism
by which EIB occurs is still a matter of debate.  However,
studies with mediator antagonists and synthesis inhibi-
tors have provided supportive evidence for the release
of mediators, such as histamine, prostaglandins and
leukotrienes, during the early asthmatic response (EAR)
after exercise [7, 8].
Since its first description in 1980 [9], there has been
considerable controversy in the literature on the potential
development of a late asthmatic response (LAR) to exer-
cise in asthma.  It is known that the occurrence of a LAR
after allergen challenge is associated with an influx of
inflammatory cells and the development of bronchial
hyperresponsiveness [10].  Therefore, if a LAR after exer-
cise does exist, it could have important consequences for
our understanding of the pathophysiological mecha-
nisms of EIB, and consequently for the therapy of asth-
ma.
A number of studies have been published describing
the occurrence of a LAR after exercise with prevalence
ranging 10–89% [11–17].  However, nearly as many stud-
ies have been unable to document a LAR [18–23].  The
experimental design of some of the studies showing a
LAR has been criticized because of the lack of "appro-
priate" control days [24], during which lung function is
being documented without exercise or following broncho-
constriction induced by inhaled histamine.  Furthermore,
when evaluating the results of these studies, there seems
to be considerable lack of agreement among the various
investigators on the definition of the LAR after exercise.
The LAR has been defined as either a 10% [12, 15],
15% [14, 20, 23] or 20% [16, 17, 19, 21], fall in lung
function (e.g. the forced expiratory volume in one sec-
ond (FEV1)) during different time-periods after exercise
challenge. However, the definition according to a fixed
percentage fall in FEV1 carries the risk of a false-nega-
tive or a false-positive diagnosis, because it does not take
into account normal diurnal variation in lung function in
the asthmatic subjects.
Recently, a paper has been published in this Journal des-
cribing statistical methods for the identification of a LAR
in individual subjects [25], using serial hourly measure-
ments of lung function on several control days.  The aim
of this analysis was to interpret challenges with allergens
or occupational sensitizers more sensitively [25], by tak-
ing into account individual day-to-day variability in pul-
monary function on control days.  In the present study,
we have therefore applied an analogous approach, using
multiple linear regression analysis for each patient, to eva-
luate the occurrence of LAR after exercise in a group of
asthmatic children.  To that end, we repeatedly measured
lung function up to 8 h after exercise challenge.  We also
measured lung function during a control day without exer-
cise (negative control), and on a day after histamine chal-
lenge inducing a matched level of bronchoconstriction to
that observed after exercise (positive control).
Methods
Patients
Seventeen children (8 males and 9 females) were recruit-
ed from the out-patient clinic of the Department of
Pediatric Pulmonology of the Juliana Childrens' Hospital
in The Hague (table 1). They were all known already at
the clinic and had a diagnosis of asthma [26]. All had a
history of exercise-induced bronchoconstriction and sho-
wed a fall in FEV1 >10% as compared to pre-exercise
FEV1 after a standardized screening exercise challenge.
Mean age of the children was 10 yrs (range 7–14 yrs)
and at screening their baseline FEV1 was >75% of pre-
dicted value [27].  All children except two were atopic
(radioallergosorbant test (RAST) class ≥2 for at least one
inhalant allergen).
All children were clinically stable (i.e. no history of
exacerbation and/or respiratory viral infection during the
2 weeks before entry into the study). Anti-inflammatory
maintenance treatment was reduced according to a stan-
dardized protocol. Sodium cromoglycate (3 out of 17) and
the anti-histamine cetirizine (2 out of 17) were stopped
2 weeks before the first study day.  The dose of inhaled
corticosteroids (7 out of 17) was halved for the first week
and, thereafter, tapered by 100 µg each week, until no
inhaled steroids had been used in the week before the
first study day. Inhaled short-acting bronchodilators were
used as rescue medication during the study period. No
bronchodilatory therapy was used for at least 8 h before
each study day.
Informed consent was obtained in all cases.  The study
was approved by the Local Hospital Medical Ethics
Committee.
Study design
All practical work was performed at the Juliana Childrens'
Hospital in The Hague.  The children attended the lung
function laboratory on four consecutive days at intervals
of at least 24 h and within a study period of 3 weeks.
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Table 1.  –  Patient characteristics
Pt Sex Age Atopy Baseline FEV1 % pred# PD20 Therapy†
No. yrs EX1 EX2 H C µg
1 M 7 + 94 92 92 96 120 salb
2 M 8 + 108 102 104 102 30 sdcg
3 F 12 + 91 95 97 90 36 bdp
4 F 11 + 105 107 107 112 55 bdp
5 M 10 + 98 91 94 93 55 salb
6 F 9 + 82 91 89 85 20 bdp
7 M 14 + 83 80 79 89 4 bud
8 F 10 + 99 98 101 101 23 bdp
9 F 12 - 113 113 103 112 31 salb
10 F 11 + 93 98 91 97 40 salb
11 F 10 + 85 85 86 86 9.2 cet
12 F 7 + 103 97 99 99 11 sdcg
13 M 11 + 102 103 102 101 90 bdp
14 M 9 + 85 84 79 79 28 salb
15 F 7 - 85 - - 94 7.6 salb
16 M 7 + 97 - - 95 5.5 cet,bdp
17 M 10 + 87 82 81 77 28 sdcg
Mean 9.7 95 95 94 95 24‡
±SD 2.0 10 9 9 11 1.4‡
#: FEV1 at start of study day expressed as percentage of predicted FEV1 (% pred); †: therapy before stan-
dardized cessation of regular treatment; ‡:geometric mean±SD in doubling doses. Pt: patient; M: male; F:
female; FEV1: forced expiratory volume in one second; EX1: exercise screening day; EX2: second exer-
cise challenge day; H: histamine inhalation day; C: control day, lung function measurement in absence of
challenge; PD20: provocative dose of histamine causing a 20% fall in FEV1; salb: salbutamol; cet: cetirizine;
sdcg: sodium dicromoglycate; bdp: beclomethasone dipropionate; bud: budesonide.
On the first day (exercise screening day = EX1-day) base-
line FEV1 was measured in triplicate followed by stan-
dardized exercise challenge. Lung function measurements
(FEV1) were made repeatedly during the recovery peri-
od, and thereafter every 30 min up to 8 h after challenge.
On the subsequent three study days, in random order,
either: a second exercise challenge (EX2-day) was per-
formed; or a histamine inhalation challenge (H-day) mat-
ching the degree of bronchoconstriction after the screening
exercise; or lung function measurements were performed
in the absence of challenge (C-day), again during the
same 8 h period. On each of the four study days, indi-
vidual children started at the same time of day, usually
9.00 a.m.  During the study days, the children stayed in
one of the rooms of the lung function laboratory abstain-
ing from strenuous exercise.
Lung function measurements
For each individual child, lung function measurements
were made either using a dry rolling-seal spirometer
(Vicatest 5; Mijnhardt, The Netherlands) or a pneumo-
tachograph (Flowscreen; Jaeger, Germany). Only one
device was used for each child. The highest FEV1 obtained
from three forced expiratory manoeuvres at each time-
point was retained for analysis [28].
Exercise challenge (EX-days)
Exercise challenge was performed by running on a
treadmill (LE 2000; Jaeger, Germany) for 6 min [29].
During the test, heart rate was checked using a heart rate
monitor (Polar Sporttester).  The children started at walk-
ing pace on the treadmill for 1 min.  Thereafter, the speed
of the treadmill was increased to induce a heart rate of
at least 90% of the maximum predicted heart rate for
each individual child (maximum heart rate = 210 - age
in years).  Knowing that the occurrence of a LAR may
be dependent upon the severity of the early asthmatic
response (EAR) to exercise [13], and knowing that the
severity of the EAR to exercise is aggravated when the
humidity of the inspired air during exercise is decreased
[30], dry air was used to increase the osmotic stress to
the airways in order to augment the EAR. This dry air
(relative humidity <15%) was inspired from a reservoir
bag through a face mask with an inspiratory and expi-
ratory port (Speak Easy II) during running. Using this
protocol in our laboratory, the intraclass correlation co-
efficient for repeatability of the bronchoconstrictor res-
ponse (expressed as percentage fall in FEV1) is 0.57 [31].
Dry air was not used when a preliminary exercise chal-
lenge had already shown severe obstruction (percentage
fall in FEV1 >45%) when breathing room air (n=3), or
in case of fear of the mask (n=1).  Lung function mea-
surements were made in triplicate before exercise as well
as 1, 3, 5, 7, 10, 15, 20, 25 and 30 min afterwards, and
then every 10–15 min, until 2 h after challenge.  Thereafter,
lung function measurements were made every 30 min up
to 8 h after exercise, allowing the calculation of the EAR
and the LAR to exercise.
Histamine challenge (H-day)
A standardized dosimetric technique was used to per-
form the histamine challenge [32]. A Rosenthal-French
dosimeter was connected to a Devilbiss nebulizer type
646.  By slow inhalation from functional residual capac-
ity (FRC) to total lung capacity (TLC), the dosimeter
was triggered to deliver a dose of histamine to the mouth.
Starting with the lowest dose of histamine diphosphate
in physiological saline, doubling doses (5–640 µg) were
then inhaled.  Three minutes after inhaling each dose of
histamine, FEV1 was measured in triplicate, the highest
FEV1 being used in the analysis. The histamine chal-
lenge ended if the percentage fall in FEV1 from base-
line did not differ by more than 10% from the percentage
fall in FEV1 as induced by the first exercise test on EX1-
day for each individual child.
During spontaneous recovery from the bronchocon-
striction to histamine, FEV1 measurements were repeat-
ed in triplicate at the same time intervals as used after
exercise challenge up to 8 h.  This allowed the calcula-
tion of the EAR to histamine in the same way as used
for exercise.  To assess bronchial responsiveness to his-
tamine, the provocative dose of histamine causing a 20%
fall in FEV1 (PD20 histamine) was determined by lin-
ear interpolation between two data points on the non-
cumulative log dose-response curve [32].
Control day (C-day)
On the control day without any challenge, the FEV1
measurements were performed in triplicate every 15 min
during the first 2 h, and thereafter repeated every 30 min
until lung function measurements had been recorded dur-
ing a time-period of 8 h.
Analysis
For analysis, EX2-day was taken as the active chal-
lenge day, while FEV1 measurements both of C-day and
H-day served as control values. The use of histamine as
a positive control challenge was based on the assump-
tion that a LAR does not occur after histamine challenge
in the time-period studied [33]. Study days were only
used for analysis if FEV1 (expressed as percentage pre-
dicted) at the start of the active challenge days and the
control days did not differ by more than 10%.
Early asthmatic response to exercise and histamine
The EAR to exercise or histamine was expressed as
maximal percentage fall in FEV1 from prechallenge base-
line value during the first hour, according to:
prechallenge FEV1-lowest FEV1 first hour
EAR= ×100%
pre-challenge FEV1
The EAR to exercise and histamine were compared
using Students' t-test of paired samples.
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Late asthmatic response to exercise
To identify a LAR after exercise, multiple regression
analysis [34] for each patient was applied based on the
half-hourly FEV1 measurements in the time-period 2–8 h
postexercise. FEV1 was taken as the dependent variable,
with day (exercise or control) and clock time (of FEV1
measurement) as independent variables.  In a first fitted
regression model, only the main effects of day and clock
time were evaluated, the effect of day for each patient
being the difference in lung function between exercise
day and control days, at each clock time.  Multiple lin-
ear regression analysis automatically provides the pro-
per t-test for this effect within each patient. However, in
the presence of a LAR, a difference in lung function
should vary with time of day. 
Therefore, in a second step, the regression model was
extended with the interaction variable of day and clock
time. Again, multiple linear regression analysis automa-
tically provides the proper F-test.  If a statistically signi-
ficant (p<0.05) interaction was found in an individual
patient, the standard error of the difference between exer-
cise day and control days as estimated in the second re-
gression model, was used to calculate a 100*(0.951/13) =
99.6% confidence interval for this difference (Bonferroni
correction). To verify the occurrence of a LAR, a graphic
representation of the difference in lung function between
the exercise day and the control days for each clock
time was drawn, together with its 99.6% confidence
interval. For a LAR to be present, at least two consec-
utive time-points had to lie outside the confidence inter-
val.
The analysis was performed using the absolute value
(L) of the FEV1 measurements at each time-point as well
as the values expressed as percentage of baseline FEV1
at the start of the study day.
Results
Thirteen children completed all four study days, and
in an additional two children data were available on at
least one exercise day and both control days.  Two child-
ren completed two study days only, due to clinical deterio-
ration of their asthma requiring therapeutic intervention,
and they were excluded from analysis. There was no sig-
nificant difference in baseline FEV1 between the exer-
cise and the control days (mean difference±SD between
EX2 day and H-day: 1.07±4.3% predicted (p=0.29); be-
tween EX2-day and C-day: 0.07±4.3% pred, (p=0.95)).
Twelve out of 17 children did not run for the full 6 min
because of discomfort associated with wheezing during
running.  The duration of the exercise test for these chil-
dren ranged 3.5–5.5 min.  Room temperature varied from
19–25˚C, depending on the season. Within the study peri-
od of an individual child, room temperature did not vary
more than 2°C. Relative humidity of the dry air ranged
4.5–9%.
Early asthmatic reaction
Maximal percentage fall in FEV1 during the first hour
after exercise or after histamine challenge is shown in
table 2. Differences in mean percentage fall in FEV1
between the challenges were not statistically significant
(mean EAR±SD after EX1: 40±16% fall; after EX2: 38±15%
fall; and after histamine: 41±11% fall; p>0.05) (fig. 1).
Late asthmatic reaction
Table 2 also shows the individual results of the multi-
ple regression analysis over the period 2–8 h postexercise.
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Table 2.  –  Early asthmatic response (EAR) after exercise and histamine challenge and the
occurrence of a LAR
Pt EAR Effect of day# p-value† Effect of day# p-value†
No. % fall in FEV1 on FEV1 interaction on FEV1 interaction
EX1 EX2 H L effect % baseline effect
1 14 14 25 -0.084* 0.94 -3.54* 0.42
2 16 34 35 -0.077* 0.072 -3.12* 0.017
3 24 18 25 +0.126* 0.99 +5.35* 0.99
4 25 35 28 -0.052* 0.58 -0.35 0.99
5 28 20 35 -0.020 1.0 +1.62 1.0
6 34 37 38 +0.029 0.12 -2.65* 0.10
7 35 48 53 -0.229* 0.84 -3.79 0.87
8 40 48 39 +0.027 0.56 +1.38 0.96
9 41 27 40 +0.009 0.60 -5.08* 0.84
10 53 62 49 -0.118* 0.88 -8.70* 0.10
11 54 53 39 +0.087* 0.80 +6.27* 0.76
12 55 30 41 -0.009 0.68 +1.04 0.56
13 58 32 60 -0.089* 0.049 -5.40* 0.040
14 58 54 53 +0.104* 0.92 +1.10 0.94
17 61 57 54 +0.223* 0.38 +8.83* 0.55
Mean 40 38 41
±SD 16 15 11
The results of the analysis is represented in two parts, with the effect of day only (first step), and the
interaction effect of day and time shown separately.  #: effect of day, i.e. difference in FEV1 between
EX2-day and mean of control days, for given time of the day, as evaluated in the first step of the
analysis; *: p<0.05 for main effect of day only; †: p-value of the interaction effect between day and
time in the second step of the analysis. For definitions see legend to table 1.
The effect of day on FEV1 in this analysis as estimated
from the first step (main effects only) is shown for each
child. In 10 out of 15 children the difference in FEV1
between EX2-day and control days, although small, was
statistically significant, with FEV1 either being lower
(n=6) or higher (n=4) on the active challenge day as
compared to control days, for given time of the day.  The
next column in table 2 shows the results of the second
step in the analysis, in which the interaction effect between
day and clock time is evaluated.  When this analysis was
performed using absolute values of FEV1, a statistically
significant interaction effect indicative of a potential LAR
was found in only 1 child (No. 13).  Repeating the analy-
sis using FEV1 expressed as percentage of baseline result-
ed in one additional child (No. 2) showing a potential
LAR.  In figures 2a and 3a, respectively, the lung func-
tion of these two children during the four study days is
represented, whilst in figures 2b and 3b, respectively, a
graphical representation of the difference in FEV1 mea-
surements between EX2-day and control days for these
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Fig. 1.  –  Mean (±SD) percentage fall in FEV1 from baseline value
during the first hour for EX1-, EX2-, H- and C-day.  FEV1: forced
expiratory volume in one second; EX1: exercise screening day; EX2:
second exercise challenge day; H: histamine inhalation day; C: con-

























































































































Fig. 2.  –  a) Lung function measurements (FEV1) during four study
days in child No. 13.         : EX1-day;         : EX2-day;        : C-
day;          : H-day. b) Difference in FEV1 (∆FEV1) between EX2
and control days for each time of the day, with the 99.6% confidence
interval, in child No. 13.  For definitions see legend to figure 1.
Fig. 3.  –  a) Lung function measurements (FEV1 % baseline) during
four study days in child No. 2.         : EX1-day;         : EX2-day;  
: C-day;         : H-day. b) Difference in FEV1 (∆FEV1) between
EX2 and control days for each time of the day, with the 99.6% con-
fidence interval, in child No. 2.  For definitions see legend to figure 1.
a)a)
b) b)
two children is given together with its 99.6% confidence
interval. As can be seen from these figures, for both chil-
dren, all differences in FEV1 measurements between
EX2-day and control days from 2–8 h postexercise are
within the confidence interval.
Discussion
In this study, we have shown the absence of a late asth-
matic response to exercise in children with mild-to-mod-
erate asthma visiting an out-patient clinic. All children
suffered an early asthmatic response to exercise.  To iden-
tify a LAR accurately, and to take into account indivi-
dual variability of diurnal variation in lung function, a
statistical method was applied using multiple regression
analysis for each patient, based on serial lung function
measurements after exercise challenge and during a posi-
tive and negative control day. These data indicate that
exercise, unlike allergens, is merely a symptomatic, and
not a causative trigger of asthma [35] leading to obstruc-
tion but not to induction of inflammation.
This is not the first study of the occurrence of a LAR
after exercise in asthmatic subjects. The results present-
ed are in agreement with those of RUBINSTEIN et al. [19]
and of BONER and co-workers [23]. In contrast, other
investigators have described the existence of a LAR aft-
er exercise in asthmatic children [11, 13, 16]. When com-
paring the results of our study with those published, a
number of methodological points need to be addressed. 
Firstly, the selection of the population studied may be
important. In our study, the children were treated for
their asthma at an out-patient clinic.  Other investigators
have used a study group of asthmatic children, resident
at special asthma clinics [16, 23]. It could be argued that
the latter population may have suffered from more severe
and uncontrollable asthma, which is often the reason for
referral to specialized clinics.
Secondly, the exercise provocation method may have
influenced the results.  In our study, as opposed to others,
most children (13 out of 17) breathed dry air during run-
ning.  Even though inspired dry air is currently the meth-
od of choice [36], we did not use this potentially strong
stimulus in three children who already showed severe
bronchoconstriction when inhaling room air.  One could
argue that this could mean a difference in the exercise sti-
mulus applied.  However, as the fall in FEV1 postexer-
cise is proportional to the total amount of water lost from
the airways [37], we do not think that this has influenced
our results, as long as the stimulus remains constant with-
in subjects.
Thirdly, and perhaps more importantly, the designs of
the different studies of the LAR after exercise merit spe-
cial consideration.  Among the 13 studies cited [11–23],
only four used randomized study days [16, 20–22].  The
choice of "adequate" control days to establish normal
diurnal variation in lung function can be considered to
be of vital importance [24]. Measurements of sponta-
neous variations in lung function have to be made both
after another nonspecific challenge, e.g. histamine or
methacholine, and during a day without any bronchial
challenge. The importance of using adequate control days
is illustrated by two studies of BONER et al. [14, 23]. In
the first study [14], only one negative control day was
used and prevalence of a LAR after exercise was found
to be 26%.  However, when the study was repeated using
multiple control days to account for normal diurnal vari-
ation in lung function, the occurrence of a LAR after
exercise could no longer be confirmed [23].  Even though,
in the latter study, lung function measurements were per-
formed both on a negative and a positive control day,
the present study is the only one in which the broncho-
constriction induced by histamine was carefully matched
for degree of bronchoconstriction after exercise.
Finally, there is considerable lack of agreement among
the various investigators about the analysis of a poten-
tial LAR.  For instance, it has not been clarified during
which time-period a LAR after exercise might occur.  In
addition, most authors define the LAR according to a
predetermined percentage fall in lung function, either
from prechallenge value [12, 14, 15, 19–21], or as com-
pared to lung function measured at an identical time-
point on a control day [13, 17, 23]. However, these
methods are somewhat arbitrary.  They carry the risk of
a false-positive diagnosis in a subject with considerable
spontaneous variability of ventilatory function, or, simi-
larly, the risk of a false-negative diagnosis if spontaneous
variability is low. To eliminate the potential confound-
ing effect of day-to-day variability in pulmonary func-
tion when identifying a LAR,  the use of statistical tests
has recently been advocated to quantify normal diurnal
variation [25], thereby allowing recognition of a LAR
after challenge with greater precision. Therefore, we have
used multiple regression analysis within each patient,
taking into account normal diurnal variation on a posi-
tive and a negative control day, to optimize the identi-
fication of a LAR after exercise in the patient group
studied.
How can the present results be interpreted?  Our results
show that in out-patients with childhood asthma, in sta-
ble conditions, avoiding antiasthma drugs, a LAR after
exercise challenge is absent. This contrasts to allergen
provocation, after which a LAR occurs in 50–75% of
asthmatics challenged [38].  During the allergen-induced
late phase reactions, an influx of eosinophils into the
bronchial system has been observed [39], also reflected
in an increase in serum eosinophil cationic protein (sECP)
[40]. The occurrence of a postallergen LAR has also been
associated with an increase in bronchial hyperrespon-
siveness to histamine, while the absence has not [41].
During the early asthmatic reaction after exercise, the
different mediators released, such as histamine, prosta-
glandins and leukotrienes [7, 8], resemble those released
during the EAR after allergen challenge [42].  However,
the absence of a postexercise LAR indicates that exer-
cise appears not to induce an inflammatory process, which
is indirectly supported by the observation that bronchial
hyperresponsiveness to histamine is not increased after
exercise provocation [23], as opposed to allergen chal-
lenge [43].
What is the clinical significance of these data?  Firstly,
in the absence of a LAR after exercise, one could argue
that it would suffice to treat patients with asthma symp-
toms occurring only after exercise symptomatically, e.g.
with a short-acting bronchodilator [44], disodium cro-
moglycate or nedocromil [45].  However, it should be
remembered that the symptom of EIB in asthma should
be interpreted as a sign of bronchial hyperresponsiveness
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[35].  It has been known for many years that the sever-
ity of EIB is moderately correlated to the severity of
methacholine-induced hyperresponsiveness [46].  In the
current concept of asthma as an inflammatory disease,
there are many studies linking bronchial hyperrespon-
siveness to inflammatory changes in the airways.  There-
fore, we think it valid to consider regular anti-inflammatory
therapy in those patients with moderate to severe EIB
[47].
In conclusion, we have shown the absence of a late
asthmatic response after exercise in childhood asthma.
This supports the concept of exercise being a sympto-
matic trigger, and thus a reflection of bronchial hyper-
responsiveness, instead of a causative factor in asthma.
However, more studies are needed in asthmatic children
to investigate the relationship between bronchial hyper-
responsiveness, exercise-induced bronchoconstriction and
inflammatory changes in the airways.
Acknowledgements: The authors wish to thank the
Medical Department of Glaxo BV and the Stichting Astma
Bestrijding for their financial support.
References
1. Floyer Sir J.  A treatise of the asthma.  London, Wilkin
and Innis, 1698.
2. Kattan M, Keens TG, Mellis CM, Levison H.  The
response to exercise in normal and asthmatic children.
J Pediatr 1978; 92: 718–721.
3. Custovic A, Arifhodzic N, Robinson A, Woodcock A.
Exercise testing revisited: the response to exercise in nor-
mal and atopic children.  Chest 1994; 105: 1127–1132.
4. Cypcar D, Lemanske RF.  Asthma and exercise.  Clin
Chest Med 1994; 15: 351–368.
5. Wiens L, Sabath R, Ewing L, Gowdamarajan R, Portnoy
J, Scagliotti D.  Chest pain in otherwise healthy children
and adolescents is frequently caused by exercise-induced
asthma.  Pediatrics 1992; 90: 350–353.
6. Makker HK, Holgate ST.  Review: mechanisms of exer-
cise-induced asthma.  Eur J Clin Invest 1994; 24: 571–585.
7. Finnerty JP, Holgate ST.  Evidence for the roles of hista-
mine and prostaglandins as mediators in exercise-induced
asthma: the inhibitory effect of terfenadine and flurbi-
profen alone and in combination.  Eur Respir J 1990; 3:
540–547.
8. Manning PJ, Watson RM, Margolskee DJ, Williams VC,
Schwartz JI, O'Byrne PM.  Inhibition of exercise-induced
bronchoconstriction by MK-571, a potent leukotriene D4-
receptor antagonist.  N Engl J Med 1990; 323: 1736–1739.
9. Bierman CW, Spiro SG, Petheram I.  Late response to
exercise-induced asthma. J Allergy Clin Immunol 1980;
65: 206.
10. Durham SR.  The significance of late responses in asth-
ma.  Clin Exp Allergy 1991; 21: 3–7.
11. Lee TH, Nagakura T, Papageorgiou N, Iikura Y, Kay
AB.  Exercise-induced late asthmatic reactions with neu-
trophil chemotactic activity. N Engl J Med 1983; 308:
1502–1505.
12. Bierman CW, Spiro SG, Petheram I.  Characterization
of the late asthmatic response in exercise-induced asth-
ma.  J Allergy Clin Immunol 1984; 74: 701–706.
13. Iikura Y, Inui H, Nagakura T, Lee TH. Factors predisposing
to exercise-induced late asthmatic responses.  J Allergy
Clin Immunol 1985; 75: 285–289.
14. Boner A, Niero E, Antolini I, Warner JO.  Biphasic (early
and late) asthmatic responses to exercise in children with
severe asthma, resident at high altitude. Eur J Pediatr
1985; 144: 164–166.
15. Boulet L-P, Legris C, Turcotte H, Hebert J.  Prevalence
and characteristics of late asthmatic responses to exer-
cise.  J Allergy Clin Immunol 1987; 80: 655–662.
16. Speelberg B, Van den berg NJ, Oosthoek CHA, Verhoeff
NPLG, Van den Brink WTJ.  Immediate and late asth-
matic responses induced by exercise in patients with
reversible airflow limitation.  Eur Respir J 1989; 2:
402–408.
17. Verhoeff NPLG, Speelberg B, Van den Berg NJ, Oosthoek
CHA, Stijnen T.  Real and pseudo late asthmatic reac-
tions after submaximal exercise challenge in patients with
bronchial asthma: a new definition for late asthmatic
responses after exercise challenge.  Chest 1990; 98:
1194–1199.
18. Dahl R, Henriksen JM.  Development of late asthmatic
reactions after allergen or exercise challenge tests.  Eur
J Respir Dis 1980; 61: 320–324.
19. Rubinstein I, Levison H, Slutsky AS, et al. Immediate
and delayed bronchoconstriction after exercise in patients
with asthma.  N Engl J Med 1987; 317: 482–485.
20. Zawadski DK, Lenner KA, McFadden ER.  Re-exami-
nation of the late asthmatic response to exercise. Am
Rev Respir Dis 1988; 137: 837–841.
21. Karjalainen J.  Exercise response in 404 young men with
asthma: no evidence for a late asthmatic reaction.  Thorax
1991; 46: 100–104.
22. Crimi E, Balbo A, Milanese M, Miadonna A, Rossi GA,
Brusasco V.  Airway inflammation and occurrence of
delayed bronchoconstriction in exercise-induced asthma.
Am Rev Respir Dis 1992; 146: 507–512.
23. Boner AL, Vallone G, Chiesa M, Spezia E, Fambri L,
Sette L.  Reproducibility of late phase pulmonary response
to exercise and its relationship to bronchial hyperreac-
tivity in children with chronic asthma. Pediatr Pulmonol
1992; 14: 156–159.
24. Lee TH, O'Hickey SP (Editorial).  Exercise-induced asth-
ma and late phase reactions.  Eur Respir J 1989; 2:
195–197.
25. Stenton SC, Avery AJ, Walters EH, Hendrick DJ.  Statisti-
cal approaches to the identification of late asthmatic reac-
tions. Eur Respir J 1994; 7: 806–812.
26. American Thoracic Society.  Standards for the diagno-
sis and care of patients with chronic obstructive pulmo-
nary disease (COPD) and asthma. Am Rev Respir Dis
1987; 136: 225–243.
27. Zapletal A, Samanek M, Paul T.  Lung function in child-
ren and adolescents: methods and reference values.  Prog
Respir Res 1987; 22: 83–112.
28. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF,
Peslin R, Yernault J-C.  Standardized lung function test-
ing: lung volumes and forced ventilatory flows. Eur
Respir J 1993; 6 (Suppl. 16): 5–40.
29. Anderson SD, Schoeffel RE.  Standardization of exer-
cise testing in the asthmatic patient: a challenge in itself.
In: Airway Responsiveness.  Mississauga, Astra Pharma-
ceuticals Ltd, 1985; 51–59.
30. Boulet L-P, Turcotte H.  Influence of water content of
inspired air during and after exercise on induced bron-
choconstriction.  Eur Respir J 1991; 4: 979–984.
31. Hofstra WB, Sont JK, Sterk PJ, Neijens HJ, Duiverman
EJ.  Repeatability of exercise-induced asthma using tread-
mill exercise challenge in asthmatic children.  Am J Respir
Crit Care Med 1995; 151: A747.
W.B. HOFSTRA ET AL.1354
32. Duiverman EJ, Neijens HJ, van der Snee van Smaalen
M, Kerrebijn KF.  Comparison of forced oscillometry
and forced expirations for measuring dose-related respon-
ses to inhaled methacholine in asthmatic children.  Bull
Eur Physiopathol Respir 1986; 22: 433–436.
33. White MV, Slater JE, Kaliner MA.  Histamine and asth-
ma.  Am Rev Respir Dis 1987; 135: 1165–1176.
34. Kleinbaum DG, Kupper LL, Muller KE.  Testing hypo-
theses in multiple regression. In: Kleinbaum DG, Kupper
LL, Muller KE, eds.  Applied Regression Analysis and
Other Multivariable Methods.  Boston, PWS Kent, 1988;
pp. 124–143.
35. Cockcroft DW.  Nonallergic airway hyperresponsiveness.
J Allergy Clin Immunol 1988; 81: 111–119.
36. Sterk PJ, Fabbri LM, Quanjer PhH, et al.  Airway respon-
siveness: standardized challenge testing with pharmaco-
logical, physical and sensitizing stimuli in adults. Eur
Respir J 1993; 6 (Suppl. 16): 53–83.
37. Argyros GJ, Phillips W, Rayburn DB, Rosenthal RR,
Jaeger JJ.  Water loss without heat flux in exercise-
induced bronchoconstriction.  Am Rev Respir Dis 1993;
147: 1419–1424.
38. O'Byrne PM, Dolovich J, Hargreave FE.  State of the
art: late asthmatic responses. Am Rev Respir Dis 1987;
136: 740–751.
39. De Monchy JGR, Kauffman HF, Venge P, et al.  Broncho-
alveolar eoinophilia during allergen-induced late-phase
asthmatic reaction.  Am Rev Respir Dis 1985; 131: 373–376.
40. Venge P, Dahl R, Peterson CGB.  Eosinophil granule
proteins in serum after allergen challenge of asthmatic
patients and the effects of anti-asthmatic medication.  Int
Arch Allergy Appl Immunol 1988; 87: 306–312.
41. Mussafi H, Springer C, Godfrey S.  Increased bronchial
responsiveness to exercise and histamine after allergen
challenge in children with asthma.  J Allergy Clin Immunol
1986; 77: 48–52.
42. Holgate S.  Mediator and cytokine mechanisms in asth-
ma.  Thorax 1993;  48: 103–109.
43. O' Byrne PM.  Allergen-induced airway hyperrespon-
siveness.  J Allergy Clin Immunol 1988; 81: 119–127.
44. Rabe KF, Jorres R, Magnussen H.  The effect of 10, 50
and 200 µg inhaled  fenoterol on exercise induced asthma.
Clin Exp Allergy 1993; 23: 440–445.
45. Morton AR, Ogle SL, Fitch KD.  Effects of nedocromil
sodium, cromolyn sodium, and a placebo in exercise-
induced asthma.  Ann Allergy 1992; 68: 143–148.
46. Kiviloog J.  The correlation between exercise-induced
bronchoconstriction and bronchial methacholine sensiti-
vity in asthma.  Pediatrics 1975; 56(Suppl.): 908–909.
47. Waalkens HJ, Van Essen-Zandvliet EEM, Gerritsen J,
Duiverman EJ, Kerrebijn KF, Knol K and the Dutch
CNSLD Study Group.  The effect of an inhaled corti-
costeroid (budesonide) on exercise-induced asthma in
children. Eur Respir J 1993; 6: 652–656.
LATE RESPONSE TO EXERCISE IN CHILDREN 1355
